Aquestive Therapeutics will announce its third quarter 2026 financial results on November 3, followed by a conference call for investors on November 4. The company, known for its innovative drug delivery technologies, will also provide updates on recent business developments. Key highlights include progress on its allergy treatment Anaphylm™ and dermatological drug AQST-108, both advancing through regulatory and clinical stages. Investors can access the live webcast and replay on Aquestive's website.
Aquestive Therapeutics' upcoming Q3 2026 financial results provide context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 27, 2026 17:43 WIB: Among 150 priced US health stocks, 69 rose and 68 fell today. Enveric Biosciences Inc (ENVB) gained 2.17% to USD 1.41 with a typical hold time of 15 days, while DENTSPLY SIRONA Inc (XRAY) also rose 2.17% to USD 9.42, showing 100% buy order activity and a longer hold time of 73 days. In contrast, Brookdale Senior Living Inc (BKD) declined 2.15% to USD 9.55 with a shorter hold time of 12 days.
Black Ore introduced Black Ore for Small Firms, an AI-powered tax automation platform designed for small to mid-sized accounting practices. It integrates with Intuit tax software, enabling firms to handle more clients without increasing staff by auto...
Alm. Brand A/S executed a share buy-back program from October 20 to 26, 2026, purchasing 1.81 million shares at an average price of DKK 17.41 each. This brings the total shares bought under the program to nearly 19.58 million, costing about DKK 324 m...
Hyphenate, an autonomous finance platform, secured $45 million in Series A funding following an 86-fold revenue increase and an 11-fold growth in customers over 12 months. Its AI-driven agents now handle 90% of routine finance work, such as invoicing...
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
